Fundamental Valuation Report Revance Therapeutics(RVNC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$27.93 (USD) 05/12/2021 Weighted Valuation$30.10 (USD) Overall RatingUndervalued by 7.8% Valuation Models Adjusted Book Value: $22.74 (USD) …

Revance Therapeutics (RVNC:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Arcus Biosciences(RCUS:NYS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$29.15 (USD) 05/12/2021 Weighted Valuation$34.57 (USD) Overall RatingUndervalued by 18.6% Valuation Models Comparables: $34.57 (USD) Valuation Methods …

Arcus Biosciences (RCUS:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Macrogenics(MGNX:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$31.86 (USD) 05/06/2021 Weighted Valuation$31.57 (USD) Overall RatingFairly valued to slightly Overvalued by 0.9% Valuation Models Comparables: $24.70 (USD) …

Macrogenics (MGNX:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Editas Medicine(EDIT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$40.99 (USD) 03/24/2021 Weighted Valuation$40.70 (USD) Overall RatingFairly valued to slightly Overvalued by 0.7% Valuation Models Adjusted …

Editas Medicine (EDIT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$17.53 (USD) 18/01/2019 Weighted Valuation$23.36 (USD) Overall RatingUndervalued by 33.2% Valuation Models Analyst Consensus: $30.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Array BioPharma(ARRY:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.70 (USD) 24/10/2018 Weighted Valuation$22.50 (USD) Overall RatingUndervalued by 64.3% Valuation Models Analyst Consensus: $26.00 (USD) (in …

Array BioPharma (ARRY:NAS) Fundamental Valuation Report Read more »

Read More